For 70 years, Evonik has been leveraging its market-leading expertise in oral excipients and related drug delivery technologies to help customers generate specific functionality outcomes for their small molecules and biologics. ... MORE

The highest load omega-3 powder ingredient in its class for dietary supplements ... MORE

As a CDMO expert we provide modern, established sites for LNP manufacturing and filling, as well as process technologies for CGMP manufacturing ... MORE

Evonik is a preferred CMO partner for APIs, HPAPIs and intermediates. Learn more about how our network, process expertise and upscaling capabilities support even the largest and most complex projects ... MORE

Dietary supplements that leverage our advanced health ingredients and oral dosage form expertise ... MORE

Our broad and flexible portfolio of drug delivery systems enables you to to optimize drug performance with superior targeting outcomes ... MORE

Our broad portfolio of parenteral drug delivery technologies, formulation development, manufacturing and filling services makes us your prefered CDMO for parenteral drug delivery. ... MORE

Evonik is transforming its Health Care business to focus on its strategic core growth areas. ... MORE

Evonik has won this year’s CPHI Pharma Award in the category “Sustainability”. The winning innovation is the plant-based squalene, PhytoSquene®, which can be used for parenteral drug delivery applications, and is the first plant-based squalene in GMP quality. ... MORE

The Global Competence Network brings together a multidisciplinary team of business, application technology and research and development experts in chemistry, cell biology, bioprocessing and media optimization across Asia, Europe and the Americas. ... MORE

Evonik is expanding its EUDRACAP® portfolio with a new functional, ready-to-fill capsule that enables the delivery of sensitive active ingredients to the ileo-colonic region. ... MORE

The new double-digit million-euro facility for drying aqueous dispersions of EUDRAGIT® polymers enables Evonik to meet the increasing demand from pharmaceutical customers for oral drug delivery solutions. ... MORE

Die neue Anlage am Standort Darmstadt ermöglicht es Evonik, die weltweit steigende Nachfrage nach oralen Darreichungssystemen für die kontrollierte Freisetzung von Wirkstoffen zu decken. ... MORE

In this interview, Colby Adolph explains the advantages of partnering with an experienced CDMO on a large-scale microbial fermentation project. ... MORE

In this article, Theresa Ledbetter discusses what made this acquisition successful, why there was an extremely high retention rate of staff at the acquired company and how the acquisition continues to benefit Evonik nearly 15 years on. ... MORE

In this interview, Whitney Moro and Tom Tice discuss what makes RESOMER® the most versatile polymeric excipient available on the market.  ... MORE

What is it like working with Evonik on a custom polymer project? In this article, Stefan Menzler takes you through three case studies where Evonik has worked with customers on tailored polymer projects.  ... MORE

By chemically coupling L-Tyrosine to glycine via a peptide bond, cQrex® GY delivers solubility that is up to 50 times higher than free L-Tyrosine at neutral pH. This means you can prepare concentrated feeds without the need to modify pH, reducing process complexity and risk. Plus, cQrex® GY is non-animal derived and chemically defined, making it a safe and reliable choice for your cell cultivation needs. Learn more in this article. ... MORE

In this interview, Eric Neuffer discusses the adoption of sustainable practices such as waste reduction, using renewable energy sources, adopting green energy principles, and investing in research and development of sustainable technologies. ... MORE